Robert F. Kennedy Jr.

are more transformative than the way that psychedelics seem to rewire your brain.

And so we're looking at that as an entire category of interventions that people ought to be able to study, ought to have good access to, and we should get it out to the public as quickly as possible.

What would be the hurdles to something like that?

Would it be somewhere that... Well, for some of them, you know, for some of them, it would be that you can do, you know, to encourage more clinical trials.

Now, there would be very strong guidelines.

I mean, this is what we're envisioning, so I can't tell you exactly what we're going to do.

But very, very strong guidelines, therapeutic guidelines.

So how they're applied, what kind of follow-up.

Because a lot of these things rewire your brain.

If you don't do follow-up, it doesn't work.

Or you have a failure rate.

So those kind of protocols are all stuff that we've been developing.

People in the administration are anxious to make this happen as quickly as possible.

I know Doug Collins over at the VA already has, I think, 21 studies going over there, and they're very, very promising.

And what are they using at the VA?

I think they're using combinations of MDMA and psilocybin.

Maybe using Ibogaine.

And I think they're looking at a number of things, including ayahuasca and Ibogaine.

Who are gonna be the people?

Yeah, you need those guidelines because you don't wanna make the wild west.